Medindia
Browse this site with No Ads Click Here
Medindia » Health Watch

Data Shows Cell-Free DNA Test Predicts Colorectal Cancer Survival

by Dr. Pavithra on September 16, 2024 at 4:01 PM
Listen to this News

Highlights:

In a major leap for cancer diagnostics, new data from the GALAXY study, presented at the 2024 European Society for Medical Oncology (ESMO) Congress, underscores the transformative potential of cell-free DNA (cfDNA) testing in colorectal cancer. Conducted by Natera, Inc., this groundbreaking research highlights how the Signatera test-an advanced tool that detects circulating tumor DNA (ctDNA)-is reshaping the landscape of cancer treatment.


By offering unprecedented insights into disease progression and treatment efficacy, this study promises to enhance survival rates and tailor personalized care for colorectal cancer patients (1).

Did You Know?
The Signatera test can predict survival rates with nearly 10 times greater accuracy compared to other biomarkers. #cancerresearch #medindia’

What is Cell-Free DNA (cfDNA)?

Cell-free DNA refers to fragments of DNA that circulate in the bloodstream. In cancer patients, a specific type of cfDNA, known as circulating tumor DNA (ctDNA), can be detected. This allows doctors to monitor cancer progression, detect recurrence, and assess how well treatments are working-all without invasive procedures like biopsies.

Cell free DNA for Colorectal Cancer

The study involved 2,240 patients with stage II-IV colorectal cancer. After surgery, patients were monitored using the Signatera test, which analyzes ctDNA levels to detect molecular residual disease (MRD)-small amounts of cancer that may remain after treatment.

Key findings include:

These results demonstrate that sustained ctDNA clearance through the Signatera test can be a strong predictor of long-term survival for colorectal cancer patients.

Cell free DNA - The Future of Personalized Medicine

Dr. Yoshiaki Nakamura, one of the study's lead researchers, highlighted how the findings reinforce the role of ctDNA as a powerful tool in predicting post-surgical outcomes. With over 2,200 patients involved, this trial provides critical evidence that Signatera can revolutionize personalized cancer treatment, improving outcomes by helping doctors make informed, data-driven decisions.

The latest findings from the GALAXY study mark a pivotal moment in colorectal cancer treatment, demonstrating that cell-free DNA testing offers a significant advance in predicting patient outcomes and tailoring therapy.

By providing clear evidence of how ctDNA can forecast overall survival and the benefits of chemotherapy, these results promise to enhance personalized treatment strategies and improve patient care. As we move forward, integrating these insights into clinical practice could transform the approach to managing colorectal cancer, offering patients a more targeted and effective path to recovery.

Reference:
  1. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial - (https:pubmed.ncbi.nlm.nih.gov/19451431/)


Source: Medindia

Cite this Article

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dr. Pavithra. (2024, September 16). Data Shows Cell-Free DNA Test Predicts Colorectal Cancer Survival. Medindia. Retrieved on Jan 30, 2025 from https://www.medindia.net/news/healthwatch/data-shows-cell-free-dna-test-predicts-colorectal-cancer-survival-217255-1.htm.

  • MLA

    Dr. Pavithra. "Data Shows Cell-Free DNA Test Predicts Colorectal Cancer Survival". Medindia. Jan 30, 2025. <https://www.medindia.net/news/healthwatch/data-shows-cell-free-dna-test-predicts-colorectal-cancer-survival-217255-1.htm>.

  • Chicago

    Dr. Pavithra. "Data Shows Cell-Free DNA Test Predicts Colorectal Cancer Survival". Medindia. https://www.medindia.net/news/healthwatch/data-shows-cell-free-dna-test-predicts-colorectal-cancer-survival-217255-1.htm. (accessed Jan 30, 2025).

  • Harvard

    Dr. Pavithra. 2024. Data Shows Cell-Free DNA Test Predicts Colorectal Cancer Survival. Medindia, viewed Jan 30, 2025, https://www.medindia.net/news/healthwatch/data-shows-cell-free-dna-test-predicts-colorectal-cancer-survival-217255-1.htm.

View Non AMP Site | Back to top ↑